Win the Fight Against Prostate Cancer
Compare Treatment Success Rates
COMPARE TREATMENT SUCCESS RATES
Men diagnosed with Intermediate to High Risk Prostate Cancer are more likely to have a relapse or recurrence of their Prostate Cancer in the years following Treatment.
Experts have done the research to find which initial prostate cancer treatments help patients remain in remission following treatment. Choose your RISK GROUP below to explore the data and understand your treatment options.
Disclaimer: Prostate Cancer Treatment Results will vary from person to person.
COMPARE TREATMENT SUCCESS RATES
Men diagnosed with Intermediate to High Risk Prostate Cancer are more likely to have a relapse or recurrence of their Prostate Cancer in the years following Treatment.
Experts have done the research to find which initial prostate cancer treatments help patients to become prostate cancer free following treatment. Choose your RISK GROUP below to explore the data and understand your treatment options.
Disclaimer: Prostate Cancer Treatment Results will vary from person to person.
LEARN TO FIGHT PROSTATE CANCER.
Top Ten Steps - Fight Prostate Cancer
Learn the Top Ten Steps, a guide through knowledge about the prostate, prostate cancer, diagnosis and treatment. Watch our video, introducing Edward Weber, MD. and hear his advice to men just diagnosed with prostate cancer. Get expert advice for your fight against Prostate Cancer.
PROSTATE CANCER FREE VIDEO LIBRARY.
UNDERSTANDING PROSTATE CANCER
What is Prostate Cancer?
What is Prostate Cancer, the Symptoms, Risk Factors? What does the Prostate do, where is it located?
Diagnosed with Prostate Cancer?
What tests confirm the presence of prostate cancer? Learn how doctors diagnose prostate cancer.
Treating Prostate Cancer.
Patients have options when it comes to the prostate cancer treatments. Learn about your options.
PROSTATE CANCER FREE MISSION
The Foundation is here to help you quickly learn about the prostate gland, cancer of the prostate, prostate cancer treatments and treatment side effects. If you are recently diagnosed with prostate cancer, you have a choice in your prostate cancer treatment. If diagnosed early, there are many options. The decision can be more complicated for patients with more advanced disease where the risk of cancer relapse is greatly increased. Relapse or recurrence is the return of cancer, requiring additional treatment. This website features information to help you determine which prostate cancer treatments are the most successful at eliminating localized cancer, increasing your odds of remaining prostate cancer free for the rest of your life.
When prostate cancer is discovered early, the risk of relapse of recurrence can be low. But if you have been diagnosed with cancer that has spread, or is more aggressive, you may fall into the Intermediate to High Risk Group. For men in these groups, choosing the best treatment, or combination of treatments provides the best chance to remain in remission following treatment. Recurrence is discovered by regularly scheduled PSA blood tests, at established intervals following treatment. Prostate Cancer Free offers a study comparing the different prostate cancer treatment outcomes for over 129,000 men, highlighting which men remained in remission and for how many years. See which treatments are most likely to keep men in remission, with no return of cancer.
The Prostate Cancer Free Foundation is a NON-PROFIT 501-C. The Foundation is completely dependent upon donations. Your tax deductible donation(s) enables the Foundation to continue the valuable work of educating men and their loved ones about prostate cancer.
PROSTATE CANCER NEWS
PCa Commentary #151: OLIGOMETASTATIC PROSTATE CANCER: Metastases Directed Therapy – Patient Selection, Imaging and Outcomes
Metastases Directed Therapy (MDT) has become a realistic option for men who develop metastases after primary therapy. The theoretical foundation of MDT was succinctly stated by David Palma, M.D., PhD: “The oligometastatic paradigm hypothesizes that...
PCa Commentary #150 – Bone Health: An Important Issue Insufficiently Acknowledged for Men on Androgen Suppression
A Commentary discussing bone health and bone protective therapy may not be as eye-catching as new developments in PSMA and Axumin imaging or radioligand therapy with Lu-177, but as the old spiritual says: “dem bones, dem bones gonna walk around …” and we...
PCa Commentary #149 – LUPRON vs FIRMAGON: Is The Debate About Superiority Over? Just the Facts, Please, … but with the December FDA approval of Relugolix the debate may now be moot.
A great deal has been written about the comparison between Lupron (leuprolide) and Firmagon (degarelix). Lupron as been the mainstay of treatment of relapsed and metastatic prostate cancer since its introduction in the early 1990’s. Firmagon (degarelix) was FDA...
Remission versus Recurrence?
Relapse of prostate cancer is way more common than you might think. Many men treated for prostate cancer have their cancer return, recurrence, which can lead to a lifetime of treatment. Prostate Cancer Free studies treatment outcomes. The STUDY, updated for 2021, is available to print or download. Relapse is determined by periodic monitoring PSA Levels in the blood. No relapse or remaining in remission for 10-15 years after prostate cancer treatment, makes it very unlikely that the cancer will ever return. Complete remission, no more treatment.
Help To Continue the Work!
The Prostate Cancer Free Foundation, reviews the results of hundreds of thousands of men treated for prostate cancer. Tracking them for years. This information is available to you, and others like you, to help find the best prostate cancer treatment. This work takes time, effort, resources all of it done by volunteers. Please help us continue. Please Donate!